# data[].attributes.attachment_link.title
Admetsys Artificial Pancreas - Diabetic Treatment. Revolutionized.

# data[].attributes.body
The artificial pancreas, a new technology created by Admetsys is currently undergoing clinical trials. By using a chip at the end of an intravenous catheter, the machine can continuously monitor glucose levels every 5 minutes and administer insulin or glucose when required (Medgadget, 2018)

# data[].attributes.body
Admetsys (2017). Diabetic treatment. Revolutionized. Retrieved from https://admetsys.com/index.html

Chase, J. G., Desaive T., Bohe, J., Cnop M., De Block, C., Gunst, J., . . . Preiser, J. (2018). Improving glycemic control in critically ill patients: Personalized care to mimic the endocrine pancreas. Critical Care 22, 182. doi:10.1186/s13054-018-2110-1

DeJournett, L., & DeJournett, J. (2016). In silico testing of an artificial-intelligence-based artificial pancreas designed for use in the intensive care unit Setting. Journal of Diabetes Science and Technology, 10(6), 1360–1371. doi:10.1177/1932296816653967

Medgadget (2018, May 17). Admetsys develops articial pancreas for critical care. Retrieved from https://www.medgadget.com/2018/05/admetsys-develops-artificial-pancreas-for-critical-care.html

# data[].attributes.body
Medgadget article published on May 17, 2018. All references used were published within the last 3 years.

# data[].attributes.body
Decrease the workload on critical care nurses. No need to take hourly blood sugars!

Reduce risk of human error

Tighter control of blood sugar which can decrease mortality and hospital length of stay

Decreased cost to the US and hospitals (Admetsys, 2017).

Eliminate severe incidents of hypoglycemia (DeJournett & DeJournett, 2016).

# data[].attributes.body
Medgadget is an independent publication by a group of MDs and biomedical engineers that has been reporting on new medical technology from around the world since 2004.

Admetsys (Advanced Metabolic Systems) is a company led by Timothy Valk, chief scientist behind the artificial pancreas.

Both articles evaluating the use of an artificial pancreas in critical care are from peer reviewed journals

# data[].attributes.body
Risk for hypoglycemia

Risk for technology malfunction (Chase et al., 2018)

# data[].attributes.body
I think this is an amazing new technology that can have an impact on patient outcomes and staff satisfaction. This can decrease the workload on nurses by eliminating hourly glucose checks and providing tighter control of glucose levels for patients. This decreases mortality by preventing episodes of severe hypoglycemia and overall decreasing costs accrued by hospitals.

# data[].attributes.body
Alice (Achiever)

She is a hard worker who is good at getting things done

Faith (Futuristic)

She inspires others with new ideas. Great for helping to get people on board with a new technology!

Fernando (Focus)

Our point person. He keeps the team on track in the right direction

Daniel (Discipline)

The organizer of the team. He keeps us structured and efficient

Louis (Learner)

Always looking for new information on the latest technology that can be implemented